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23 Teratomas are tumors consisting of components of the three germ layers that differentiate 
24 from pluripotent stem cells derived from germ cells. In the normal mouse testis, teratomas 
25 rarely form, but a deficiency in Dead-end1 (Dnd1) in mice with a 129/Sv genetic 
26 background greatly enhances teratoma formation. Thus, DND1 is crucial for suppression 
27 of teratoma development from germ cells. In the Dnd1 mutant testis, nascent teratoma 
28 cells emerge at E15.5. To understand the nature of early teratoma cells, we established 
29 cell lines in the presence of serum and leukemia inhibitory factor (LIF) from teratoma-
30 forming cells in neonatal Dnd1 mutant testis. These cells, which we designated cultured 
31 Dnd1 mutant germ cells (CDGCs), were morphologically similar to embryonic stem cells 
32 (ESCs) and could be maintained in the naïve pluripotent condition. In addition, the cells 
33 expressed pluripotency genes including Oct4, Nanog, and Sox2; differentiated into cells 
34 of the three germ layers in culture; and contributed to chimeric mice. The expression 
35 levels of pluripotency genes and global transcriptomes in CDGCs as well as these cells’ 
36 adaption to culture conditions for primed pluripotency suggested that their pluripotent 
37 status is intermediate between naïve and primed pluripotency. In addition, the teratoma-
38 forming cells in the neonatal testis from which CDGCs were derived also showed gene 
39 expression profiles intermediate between naïve and primed pluripotency. The results 
40 suggested that germ cells in embryonic testes of Dnd1 mutants acquire the intermediate 
41 pluripotent status during the course of conversion into teratoma cells.
42
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48 Primordial germ cells (PGCs) are undifferentiated germ cells in embryos, and normally 
49 develop into eggs or sperm. In culture, PGCs can be reprogrammed to pluripotent stem 
50 cells (PSCs), also called embryonic germ cells (EGCs), by specific cytokines (Matsui et 
51 al., 1992; Resnick et al., 1992) and/or small molecule compounds (Leitch et al., 2013). 
52 Spermatogonial stem cells (SSCs) also develop into PSCs in the presence of certain 






























































54 mice, indicating that their primitive pluripotency is similar to that of the pre-implantation 
55 epiblast and embryonic stem cells (ESCs) that are derived from the epiblast; this state is 
56 referred to as naïve pluripotency. Cell lines derived from the post-implantation epiblast, 
57 which are called epiblast stem cells (EpiSCs), possess more restricted pluripotency, which 
58 is referred to as primed pluripotency (Nichols and Smith, 2009).
59 In some conditions, teratomas, which are believed to arise from undifferentiated germ 
60 cells, develop in vivo and consist of differentiated tissues and cells of the three germ 
61 layers (Stevens and Little, 1954). Teratomas are rarely found in mice, but specific genetic 
62 backgrounds such as the 129/Sv strain and/or mutations including Ter markedly enhance 
63 teratoma development (Stevens, 1973; Noguchi and Noguchi, 1985). In humans, about 
64 one-third of childhood testicular cancers are teratomas (Bustamante-Marin et al., 2013). 
65 In teratocarcinomas, pluripotent embryonic carcinoma cells (ECCs) are retained. A 
66 number of ECC lines have been established from teratocarcinomas in mice and humans, 
67 and studies have reported that ECC lines are pluripotent (Kleinsmith and Pierce Jr., 1964; 
68 Mintz and Illmensee, 1975; Papaioannou et al., 1978). However, their pluripotency is 
69 sometimes restricted (Kelly and Gatie, 2017) compared to that of ESCs and EGCs.
70 Dnd1 was identified as a gene that is allelic with the Ter mutation (Dnd1ter/ter) 
71 (Youngren et al., 2005). In Dnd1ter/ter mice, a point mutation that introduces a stop codon 
72 is present in the third exon of Dnd1. Dnd1 encodes an RNA-binding protein that has been 
73 shown to associate with uridine-rich regions in the 3′-untranslated region of target 
74 mRNAs, thereby protecting the mRNAs from microRNA-mediated translation repression 
75 (Kedde et al., 2007). A recent study reported that DND1 destabilizes target mRNAs via 
76 recruitment of the CCR-NOT deadenylase complex in PGCs and SSCs (Yamaji et al., 
77 2017). These results suggest that DND1 either stabilizes or destabilizes different target 
78 mRNAs via distinct mechanisms in germ cells. Previous studies identified Cdkn1a and 
79 Cdkn1b, which encode negative regulators of the cell cycle (p21cip1 and p27Kip, 
80 respectively) and whose expression is down-regulated in germ cells in Dnd1ter/ter embryos, 
81 as teratoma-related target mRNAs of DND1 (Cook et al., 2011). We also found that 
82 DND1 targets the transcript encoding Ezh2, a histone H3K27 trimethyl transferase, which 
83 causes down-regulation of the cell cycle control protein CCND1, in germ cells (Gu et al., 
84 2018). These results together suggest that enhancement of the cell cycle is likely a key 
85 event in the conversion of germ cells into teratomas. Although pluripotent ECC lines can 






























































87 from nascent teratoma cells has not been reported. 
88  In Dnd1ter/ter embryonic testes, only a few germ cells are found, but some of these germ 
89 cells start to proliferate and form small clusters of nascent teratoma cells at embryonic 
90 day 15 (E15) (Stevens, 1971). In our previous study, we detected cell clusters expressing 
91 pluripotency markers such as 4C9 and SSEA1 by E17.5 (Gu et al., 2018). We designated 
92 these cells, which likely initiate teratoma development, as teratoma-forming cells. 
93 Although the emergence of differentiated cells in nascent teratomas in perinatal testes 
94 suggests that the teratoma-forming cells are pluripotent, the detailed cellular status of the 
95 teratoma-forming cells has not been described and is important for further understanding 
96 the process of conversion of germ cells into teratoma-forming cells. In this study, we 
97 show the derivation and characterization of cell lines from teratoma-forming cells in 
98 Dnd1ter/ter testes. Our results suggest that cell lines derived from early teratoma cells show 
99 an intermediate cellular status between naïve and primed pluripotency. 
100
101
102 2. Materials and methods
103 2.1 Mice and genotyping
104 Oct4-deltaPE-GFP transgenic mice with the B6D2F1 background (Yoshimizu et al., 
105 1999) were backcrossed to 129/Sv/Dnd1ter/+ mice obtained from The Jackson Laboratory 
106 for more than 10 generations to establish a congenic strain of 129Sv/Dnd1ter/+/Oct4-
107 deltaPE-GFP mice. Female and male 129Sv/Dnd1ter/+/Oct4-deltaPE-GFP mice were 
108 mated in the afternoon, and the presence of vaginal plugs was checked the next morning. 
109 The day on which a plug was found was considered to be E0.5. DNA was extracted from 
110 the tail of the embryos, and was genotyped using the primer set TerF:5’-
111 TCCAGGAGACACTGCTGCTA-3’ and TerR:5’- TTCAGGAACTCCACTTGTGC-3’ 
112 according to the protocol provided on The Jackson Laboratory website 
113 (https://www2.jax.org/protocolsdb/f?p=116:5:0::NO:5:P5_MASTER_PROTOCOL_ID,
114 P5_JRS_CODE:2172,000091). The mice were kept and bred in the Animal Unit of the 
115 Institute of Development, Aging and Cancer, Tohoku University, which is a controlled-
116 environment and pathogen-free facility, according to the guidelines for the care and use 
117 of experimental animals defined by the facility. Animal protocols were reviewed and 































































120 2.2 HE staining and Immunohistochemistry
121 Embryonic gonads were collected from embryos on E18.5 to P7 in DMEM containing 
122 10% fetal bovine serum (FBS). Gonads were fixed in Bouin for overnight at 4°C. Samples 
123 were embedded in paraffin after dehydrtation, and were sectioned at 4 μm, which were 
124 further processed for HE staining or immunostaining. For frozen sections, Gonads were 
125 fixed in 4% paraformaldehyde (PFA) for 3h at 4°C. Fixed gonads were then soaked in 
126 10% sucrose for 1 h at 4°C, and then in 20% sucrose overnight at 4°C. Samples were 
127 embedded in O.C.T. compound (Tissue Tek), and were sectioned at 8 μm. For 
128 immunostaining, the sections were blocked in 5% skim milk/1% Triton X-100 in 
129 phosphate-buffered saline (PBS), and were incubated overnight at 4°C in the primary 
130 antibodies diluted in 1% skim milk/0.1% Triton X-100 in PBS. For cultured cells, samples 
131 were fixed in 4% PFA for 3h at room temperature, and treated in 1% Triton X-100 in PBS 
132 for 15 min, then blocked in 10% FBS/1% BSA/0.1% Triton X-100 in PBS for 1h. Samples 
133 were incubated for overnight at 4°C in the primary antibodies diluted in the same solution 
134 as for blocking; the antibodies included rat anti-4C9 (1:150 dilution; Yoshinaga et al., 
135 1991), rat anti-SSEA1 (1:100 dilution; Santa Crus, sc-21702), mouse anti-α smooth 
136 muscle actin (1:600 dilution; Sigma-Aldrich, A5228), rabbit anti-β tubulin (1:1000 
137 dilution; Sigma-Aldrich T2200), mouse anti-Foxa2 (HNF3β) (1:100 dilution; Santa Cruz, 
138 sc-374376), goat anti-Otx2 (1:200 dilution; R&D; AF1979), mouse anti Oct4 (1:300 
139 dilution; Santa Cruz; sc-5279). After washing, sections or cells were incubated with HRP 
140 anti-rat IgG (1:200 dilution), HRP anti-mouse IgG (1:200 dilution), Alexa Fluor 568 anti-
141 rabbit IgG (1:500 dilution; Invitrogen), Alexa Fluor 568 anti-rat IgG (1:500 dilution; 
142 Invitrogen), Alexa Fluor 568 anti-mouse IgG (1:500 dilution; Invitrogen) or AlexsaFlior 
143 568 anti-goat IgG (1:500 dilution; Invitrogen) for 1 h at room temperature. For 
144 fluorescence, samples were stained with 1μg/ml DAPI or Hoechst33342. Images were 
145 taken using a Leica AF6000 Microscope or SP8 Confocal Microscope.
146
147 2.3 Derivation and culture of CDGCs
148 All cells were cultured in an atmosphere of 5% CO2 at 37°C. Oct4-deltaPE-GFP 
149 expressing cell clusters were manually isolated from Dnd1ter/ter testis at P2 and dissociated 
150 them by 1x Trypsine/EDTA (Sigma), then seeded on Mitomycin C-treated feeder layer 
151 of mouse embryonic fibroblast (MEF) in 96-well plate (Falcon) with medium containing 






























































153 sodium pyruvate (Gibco), 100 μM 2-mercaptoethanol, and 1000 U/μl leukemia inhibitory 
154 factor (LIF) (Millipore). For subculture, the cells were dissociated by 1x Trypsin/EDTA 
155 and seeded on a fresh feeder layer. After two to five times subculture, single colonies 
156 were isolated and seeded on a fresh MEF feeder layer after dissociation to establish 
157 CDGC lines. The cell lines were maintained in the same medium or in N2B27 (Gibco) 
158 supplemented with 1000U/μl LIF, 1 μM PD0325901 and 3 μM CHIR99021(2i). The cell 
159 lines were also cultured in EpiSC medium (N2B27 medium containing activin A (20 
160 ng/ml; Peprotech), bFGF (12 ng/ml; Invitrogen), and KSR (20%; Invitrogen) ), and were 
161 passaged every 3 days by dissociating with collagenase IV (1 mg/ml; Invitrogen) on MEF 
162 feeder (Hayashi et al., 2011).
163
164 2.4 Induction of CDGC differentiation
165 CDGCs were induced to cardiac muscle cells as described previously (Hescheler et al., 
166 1997). CDGCs labeled with Oct4-deltaPE-GFP were purified by cell-sorting (S3e Cell 
167 Sorter, Bio-Rad), and were suspended in medium containing alpha-MEM (Gibco), 10% 
168 FBS, 10 μM MEM Non-Essential Amino Acids (Gibco), 1 mM sodium pyruvate (Gibco), 
169 2 mM L-glutamine (Gibco), 100 μM 2-mercaptoethanol at 2.5 × 104 cells/ml. 20 μl of the 
170 cell suspension was culture in hanging drops for four days to form embryoid bodies. Two 
171 or three embryoid bodies were transferred to a well of gelatin-coated 24-well plate in the 
172 same medium and were cultured until beating cells were found. Differentiation to neural 
173 cells was carried out as described with minor modifications (Watanabe et al., 2005). 20 
174 μl of cell suspension of CDGCs in medium containing G-MEM (Gibco), 5% KSR (Gibco), 
175 10 μM MEM Non-Essential Amino Acids (Gibco), 1 mM sodium pyruvate (Gibco), 100 
176 μM 2-mercaptoethanol at 5.6 × 104 cells/ml was cultured in hanging drops for 5 days. The 
177 embryoid bodies were transferred to gelatin-coated 24-well plates in the same medium 
178 with 100-200 embryoid bodies/cm2 and were cultured for three days. For differentiation 
179 to endodermal cells (Ueda et al., 2010), 15 μl of cell suspension of CDGCs in medium 
180 containing D-MEM (Gibco), 10% FBS, 10 μM MEM Non-Essential Amino Acids 
181 (Gibco), 1 mM sodium pyruvate (Gibco), 100 μM 2-mercaptoethanol, 1x 
182 penicillin/streptomycin at 3.3 × 104 cells/ml was cultured in hanging drops for 6 days. 50 
183 embryoid bodies were transferred to a well of 6-well plates in the same medium and were 































































186 2.5 Production of chimeric mice 
187 Production of chimeric mice was carried out as described (Matsui et al., 2014). 
188 Approximately 10 CDGC1-P3-9 cells cultured in 2i/LIF condition were injected into each 
189 blastocyst obtained from MCH mice (Japan SCL), and then transferred into the uterus of 
190 pseudo-pregnant female MCH mice.
191
192 2.6 ESC culture and Dnd1 knock-down
193 For Dnd1 knock-down (KD), shRNA vector (pKLO.1-shDnd1, Gu et al., 2018) or control 
194 empty vector (pKLO.1) was transfected to E14tg2a ESCs by using Lipofectamine 2000 
195 (Invitrogen) according to the manufacturer’s instruction. The E14tg2a ESCs were 
196 cultured in the same serum/LIF medium for culturing CDGCs without feeder cells. 
197 2μg/ml of Puromycin was added after 6 h for selecting cells harboring the introduced 
198 gene, and the cells were recovered after 36 h to purify total RNA. We confirmed that the 
199 expression of Dnd1 was decreased to about 15% of the expression in control cells (data 
200 not shown). BVSC ESCs (Hayashi et al., 2011; kindly gifted by Dr. M. Saitou) were 
201 culture in 2i/LIF medium without feeder cells, and induced to EpiLCs as described 
202 (Hayashi et al., 2011). D3 ESCs were cultured in the serum/LIF medium on MEF feeder.
203
204 2.7 Mouse EpiSCs Culture
205 Mouse EpiSCs (kindly gifted by Dr. H. Niwa) were cultured on gelatin-coated dishes 
206 with MEF (mouse embryonic fibroblasts) in DMEM/F-12 (Gibco) supplemented with 
207 20% KSR (Gobco), 0.1 mM non-essential amino acid (NEAA; Gibco), 1 mM sodium 
208 pyruvate (Gibco), 0.2 mM L-glutamine (Sigma), 0.1 mM β-mercaptoethanol (Sigma), 10 
209 ng/ml Activin A (R&D), and 5 ng/ml bFGF (Sigma).
210
211 2.8 RT-qPCR
212 Total RNA was purified from FACS-purified GFP-positive CDGCs, Dnd1-KD or control 
213 ESCs by RNeasy Plus Mini Kit (QIAGEN) by RNeasy Micro Kit (QIAGEN) according 
214 to the manufacturer’s instruction. Using random primers and SuperScript III Reverse 
215 Transcriptase (Invitrogen), cDNA was synthesized. 2× Power SYBR Green PCR Master 
216 Mix (Applied Biosystems) was used for real-time qPCR in 20 μl of reaction solution 
217 containing 1 μl of cDNA, 8 μl of Milli-Q water, and 1 μl of 10 μM gene-specific forward 






























































219 shown in Table S3. qPCR was performed using a CFX Connect Real-Time System (Bio-
220 Rad). The cycling conditions were as follows: 50°C for 2 min (one cycle); 95°C for 10 
221 min (one cycle); and 95°C for 15 s and 60°C for 2 min (45 cycles). 
222
223 2.9 RNA-seq
224 CDGCs labeled with Oct4-deltaPE-GFP were cultured in serum/LIF medium on MEF 
225 feeder, Dnd1-KD E14tg2a ESC and control E14tg2a ESCs (129/Ola background) were 
226 purified by cell-sorting (S3e Cell Sorter, Bio-Rad). RNA-seq libraries were prepared from 
227 500 ng of total RNA purified from CDGC1-P3-9, CDGC6-P5-6, Dnd1-KD ESCs and 
228 control ESCs of two biological replicates, with TruSeq RNA sample prep kit v2 
229 (Illumina). The libraries were clonally amplified on a flow cell and sequenced on 
230 HiSeq2500 (HiSeq Control Software v2.2.58, Illumina) with 51-mer single-end sequence. 
231 Image analysis and base calling were performed using Real-Time Analysis Software 
232 (v1.18.64, Illumina). For gene expression analysis, reads were mapped to the mouse 
233 genome (UCSC mm10 genome assembly and NCBI RefSeq database) using TopHat2 
234 and Bowtie. Cufflinks was used to estimate gene expression levels based on reads per 
235 kilobase of exon per million mapped reads (RPKM) normalization. Differentially 
236 expressed genes (DEGs) were extracted from the Cuffdiff results with statistical 
237 significance (q<0.05). DAVID Bioinformatics Resources 6.8 was used for pathway 
238 analysis, and GeneSpring (Tomy Degital Bio) was used for generating scatter plots and 
239 PCA. The GEO accession number for the RNA-seq data reported in this manuscript is 
240 GSE118582. RNA-seq data (two biological replicates in each sample except for EpiSC_1 
241 and E16.5_mGC) were also obtained from data base; D3 GFP ESC (129Sv background; 
242 SRR827706, SRR827707; Brady et al., 2013), EpiSC_1 (129Sv background; 
243 SRR3317447; Fiorenzano et al., 2016), EpiSC_2 (B6 background; SRR1660269, 
244 SRR1660270; Wu et al., 2015), E11.5 male(m)PGCs (B6 background; SRR648693, 
245 RSS648694; Yamaguchi et al., 2012), E13.5 mPGCs (B6 background; SRR649339, 
246 SRR649340; Yamaguchi et al., 2012), and E16.5 male germ cells (mGC) (B6 
247 background; ERR192339; Seisenberger et al., 2012)
248
249 2.10 Bisulfite sequencing of imprinted genes
250 Bisulfite sequencing was carried out as described (Sekinaka et al., 2016). Genomic DNA 






























































252 medium using DNeasy Blood & Tissue kits (QIAGEN). 10 ng of genomic DNA was 
253 converted with sodium bisulfite using the EZ DNA Methylation-Direct Kit (Zymo 
254 Research) according to manufacturer’s instructions. The targeted regions of H19, 
255 Igf2 and Snrpn were amplified by nested PCR from bisulfite-converted DNAs using 
256 BIOTAQ HS DNA Polymerase (BIOLINE). The sequences of the PCR primers used for 
257 this assay are listed in Table S3 (Kim et al., 2013). The PCR products were purified 1.5% 
258 agarose gel electrophoresis and the QIAquick Gel Extraction Kit (QIAGEN). The 
259 purified-samples were cloned into pGEM-T easy vectors (Promega) and were sequenced 
260 using SP6 primer and the BigDye Terminator v1.1 Cycle Sequencing Kit (Applied 
261 Biosystems). The sequence data were analyzed with the QUantification tool for 
262 Methylation Analysis (http://quma.cdb.riken.jp/top/index.html).
263
264 2.11 Single cell RT-qPCR
265 Oct4-deltaPE-GFP expressing single cells from Dnd1ter/ter testis at P2, and BVSC ESCs 
266 cultured in 2i/LIF medium were manually isolated after trypsin treatment. Preparation of 
267 cDNA form single cells was carried out as described previously with minor modifications 
268 (Kurimoto et al., 2006). A single cell with 0.5 μl of PBS was put in 4.5 μl of Lysis Mix 
269 (10 mM Tris-HCl, 50 mM KCl, 1.5 mM MgCl2, 0.5% NP-40, 5 mM DTT (Invitrogen), 
270 0.2 ng/μl Primer V1, 0.4 units/μl RNase inhibitor (Promega), 0.2 mM dNTPs (Roche)). 
271 Primer sequences are shown in Table S3. After centrifugation at 6,700 x g for 15 sec, cell 
272 lysates were incubated at 70 °C for 90 sec and 4 °C for 1 min. 40 units (0.2 μl) of 
273 SuperScript III, 1 units (0.025 μl) of RNase inhibitor and 0.875 μl of MillQ water were 
274 added to each sample which was further incubated at 50 °C for 60 min, 70 °C for 10 min 
275 and 4 °C for 1 min. After centrifugation at 16,100 x g for 10 sec, 0.1 μl of Endonuclease 
276 buffer (New England Biolabs) and 0.5 units (0.025μl) of Endonuclease I (New England 
277 Biolabs) were added to each sample which was further incubated at 37 °C for 30 min, 80 
278 °C for 25 min and 4 °C for 1 min. After centrifugation at 16,100 x g for 10 sec, 6 μl of 
279 TdT Mix (10 mM Tris-HCl, 50 mM KCl, 1.5 mM MgCl2, 3 mM dATP (Roche), 0.1 
280 units/μl of RNase H (Invitrogen), 0.8 units/μl of TdT (Roche)) was added to each sample 
281 which was incubated at 37 °C for 15 min, 70 °C for 10 min and 4 °C for 1 min. 3 μl 
282 aliquots of each sample were added to 19 μl of PCR Mix I (1x ExTaq Buffer (Takara), 1 
283 mM dNTPs, 0.05 units/μl ExTaq polymarase (Takara), 0.02 μg/μl Primer V3). After 






























































285 for 2 min, 72 °C for 3 min and 4 °C for 1 min. After centrifugation at 2,000 x g for 10 
286 sec, 19 μl of PCR Mix II (1x ExTaq Buffer, 1 mM dNTPs, 0.05 units/μl ExTaq 
287 polymarase, 0.02 μg/μl Primer V1) was added to each sample, and centrifugation at 2,000 
288 x g for 10 sec. Samples were then incubated at 95 °C for 30 sec, 67 °C for 1 min, 72 °C 
289 for 3 min (+ 6 sec in each cycle) (20 cycles) and were kept at 4 °C. Samples were then 
290 purified by QIA quick column (QIAGEN) with 50 μl of final elution volume. 1 μl of each 
291 sample was used for RT-qPCR. The primer sequences are shown in Table S3.
292
293 2.12 Statistical analysis
294 Statistical analysis was performed using the Student’s t-test. p-values < 0.05 were 




299 3.1 Derivation of pluripotent stem cells from the teratoma-forming cells in the Dnd1ter/ter 
300 testis
301  To identify appropriate developmental stages of the Dnd1ter/ter testis for derivation of 
302 cell lines from teratoma-forming cells, we first detected SSEA1-expressing cells, which 
303 are likely pluripotent, in the Dnd1ter/ter testis at different developmental stages. We found 
304 SSEA1-positive cell clusters at E18.5 (Fig. 1B), whereas Oct4-deltaPE-GFP-expressing 
305 germ cells were rarely observed in the Dnd1ter/ter testis at E18 and subsequently (Gu et 
306 al., 2018). The SSEA1-positive cell clusters also were observed at post-natal days 2 and 
307 4 (P2 and P4), but by P7, those cells had disappeared (Fig. 1B). In addition, eosin-positive 
308 areas at P4 and cavitated areas at P7, which are likely associated with differentiating 
309 teratomas, were observed (Fig. 1A). These results confirmed that SSEA1-positive cells 
310 exist in the Dnd1ter/ter perinatal testis, in agreement with previous observations (Stevens, 
311 1981), and that the testes from E18.5 to P4 may be suitable for derivation of cell lines.
312  To further confirm the presence of teratoma-forming cells in the P2 testis used for 
313 establishing cell lines, we assessed the expression of 4C9, an additional pluripotency 
314 marker, as well as that of the Oct4-deltaPE-GFP reporter, in the cell clusters at P2 (Fig. 
315 2A, B) (Gu et al., 2018). We then isolated and dissociated the Oct4-deltaPE-GFP-
316 expressing cell mass from the Dnd1ter/ter testis at P2, and cultured the cells in the 






























































318 mouse ESCs from pre-implantation blastocysts. One day after plating the cells, we 
319 observed isolated single Oct4-deltaPE-GFP-positive cells; by day 5 in culture, those cells 
320 had formed densely packed, dome-shaped colonies (Fig. 2C, upper two rows). We 
321 repeated the subculture 2-5 times by treating whole wells with trypsin (Fig. 2C, third row), 
322 and isolated single colonies to establish cell lines (Fig. 2C, bottom row). We designated 
323 the resulting cell lines “cultured Dnd1 mutant germ cells” (CDGCs). We obtained seven 
324 cell lines from the first trial, one of which is CDGC1-P3-9, and six more lines from an 
325 independent primary culture, one of which is CDGC6-P5-6 (Fig. S1A). These cell lines 
326 maintained an undifferentiated cellular status after 19 cycles of subculturing. In addition, 
327 these cells were able to acquire a cultured naïve pluripotent state in 2i (PD0325901 and 
328 CHIR99021)/LIF-containing medium (Fig. 2D, Fig. S1B) (Nichols and Smith, 2009).
329
330 3.2 Gene expression profiles of CDGCs
331  To assess the pluripotency of CDGCs at the molecular level, we used RT-qPCR to 
332 examine the expression of pluripotency-associated genes in CDGCs cultured in the 
333 serum/LIF condition. Among pluripotency-related genes (Nichols and Smith, 2009), Oct4, 
334 Nanog, and Sox2 exhibited higher expression in CDGCs than in primed EpiSCs, while 
335 demonstrating similar expression in CDGCs and in naïve ESCs (Fig. 3A). The expression 
336 of these core pluripotency genes in ESCs and EpiSCs was similar to each other’s 
337 expression levels in several previous studies, but a low level of expression previously was 
338 reported in some EpiSCs (Murayama et al., 2015), suggesting that the expression of these 
339 genes depends on the EpiSC line. 
340 The expression of the naïve pluripotency genes Esrrb, Tbx3, and Klf4 was significantly 
341 lower in CDGC1-P3-9 compared with that in ESCs and similar in CDGC1-P3-9 and 
342 EpiSCs (Fig. 3B). In CDGC6-P5-6, the expression of these genes was relatively high 
343 compared with that in EpiSCs (Fig. 3B), suggesting that CDGC1-P3-9 and CDGC6-P5-
344 6 cultured in serum/LIF medium may differ in the expression of naïve pluripotency genes. 
345 In the case of primed pluripotency genes (Nichols and Smith, 2009), the expression of 
346 Otx2 in CDGCs was significantly higher than that in ESCs and lower than that in EpiSCs. 
347 The expression level of Fgf5 was nominally higher in CDGCs than in ESCs, and the 
348 expression of Sox17 was nominally lower in CDGCs than in EpiSCs (Fig. 3C). Therefore, 
349 the expression levels of naïve and primed pluripotency genes were not consistent in 






























































351 status between naïve and primed pluripotency with regard to the expression of 
352 pluripotency genes. 
353 We also examined the expression of OTX2 by immunostaining. In ESCs cultured in the 
354 2i/LIF condition and in epiblast-like cells (EpiLCs), the OTX2 signals were 
355 homogeneously weak and strong, respectively, whereas OTX2 expression was 
356 heterogeneous in CDGCs cultured in the serum/LIF condition (Fig. S2). Oct4-deltaPE-
357 GFP-positive cells, which correspond to naïve pluripotent cells in CDGCs, showed 
358 relatively weak OTX2 expression compared to GFP-negative cells, suggesting that 
359 CDGCs in serum/LIF medium are maintained as a mixture of relatively naïve and primed 
360 pluripotent cells. After culturing in the 2i/LIF condition, CDGCs consistently showed 
361 pluripotency gene expression corresponding to naïve pluripotency (Fig. S3). 
362  To comprehensively compare molecular signatures of CDGCs with those of ESCs, 
363 EpiSCs, and PGCs, we performed transcriptomic analysis. Specifically, we performed 
364 RNA-seq for two biological replicates each of CDGC1-P3-9, CDGC6-P5-6, E14tg2a 
365 ESCs, and Dnd1-KD E14tg2a ESC (GSE118582). We also obtained published RNA-seq 
366 data for D3 GFP ESC (SRR827706, SRR827707; Brady et al., 2013), EpiSC_1 
367 (SRR3317447_1, SRR3317447_2; Fiorenzano et al., 2016), EpiSC_2 (SRR1660269, 
368 SRR1660270; Wu et al., 2015), E11.5 male(m)PGCs (SRR648693, RSS648694; 
369 Yamaguchi et al., 2012), E13.5 mPGCs (SRR649339, SRR649340; Yamaguchi et al., 
370 2012), and E16.5 male germ cells (mGS) (ERR192339; Seisenberger et al., 2012).
371 Differentially expressed genes (DEGs) between CDGC1-P3-9 and E14tg2a ESCs, and 
372 between CDGC6-P5-6 and E14tg2a ESCs, which were cultured in the serum/LIF 
373 condition, were 13.2% and 4.1% of the total genes, respectively (Fig. 4A). DEGs between 
374 CDGC1-P3-9 and EpiSCs_1 were 14.0% of the total genes. Principal component analysis 
375 (PCA) showed that gene expression profiles of CDGC6-P5-6 were more closely related 
376 to those of ESCs, especially Dnd1-KD ESCs, compared to those of EpiSCs, whereas 
377 CDGC1-P3-9 was less closely related to ESCs, instead appearing to resemble EpiSCs 
378 (Fig. 4B). These results suggested that CDGC1-P3-9 and CDGC6-P5-6 possess slightly 
379 different cellular statuses, i.e., CDGC6-P5-6 is more closely related to ESCs, whereas 
380 CDGC1-P3-9 is intermediate between ESCs and EpiSCs. 
381 To estimate the influences of Dnd1 deficiency on ESCs, we also compared gene 
382 expression in Dnd1-knockdown (KD) ESCs with that in control E14 tg2a ESCs (Fig. 4A). 






























































384 minimally affects gene expression in ESCs. Meanwhile, PCA showed that Dnd1-KD 
385 ESCs were closely correlated to CDGC6-P5-6, suggesting that deficiency in Dnd1 
386 contributes (to some extent) to transcriptomic differences between CDGCs and ESCs. 
387 Both CDGC lines were distinct from male germ cells in embryonic gonads at E11.5 to 
388 E16.5 (Fig. 4B). Consistent with this observation, the expression levels of core and 
389 primed pluripotency genes and the male germ cell markers Nanos2 (Suzuki and Saga, 
390 2008) and Dnmt3l (Bourc’his and Bester, 2004) in CDGCs were higher and lower, 
391 respectively, than in male germ cells (Fig. S4, Table S2).
392
393 3.3 CDGCs cultured in the primed pluripotency condition
394 As mentioned above, CDGCs were established in the serum/LIF condition, and could 
395 be adapted to the 2i/LIF condition. Gene expression profiles suggested that CDGCs 
396 possessed an intermediate status between naïve and primed pluripotency. We further 
397 tested whether CDGCs could be adapted to a culture condition of primed pluripotency. 
398 We transferred CDGCs cultured in serum/LIF medium into EpiSC medium containing 
399 Activin A and basic fibroblast growth factor (bFGF). After three passages, many colonies 
400 were observed but these colonies became flattened, and Oct4-deltaPE-GFP expression 
401 was down-regulated, while OCT4 protein persisted in those colonies (Fig. S5). These 
402 observations suggested that CDGCs are converted to a more primed pluripotent status in 
403 the primed culture condition.
404
405 3.4 Differentiation potential of CDGCs
406  Gene expression profiles suggest that CDGCs are PSCs. To confirm this, we first tested 
407 differentiation of CDGCs into typical cells of the three germ layers via embryoid body 
408 formation in vitro. CDGCs gave rise to differentiated cells expressing α-smooth muscle 
409 actin (α-SMA), β-tubulin, and Forkhead box (Fox) a2, which represent mesodermal 
410 cardiac muscle, ectodermal neurons, and endodermal cells, respectively (Fig. 5A, Fig. 
411 S6). In addition, we observed that some α-SMA- and hepatocyte nuclear factor (HNF) -
412 3β-expressing cells showed beat and peristaltic movements, respectively, consistent with 
413 expected tissue function. Therefore, CDGCs can differentiate into cells of the three germ 
414 layers.
415  We then introduced CDGC1-P3-9 cultured in 2i/LIF medium but not in serum/LIF 






























































417 pluripotency gene expression in CDGC1-P3-9 in the serum/LIF condition was partially 
418 distinct from a typical naïve profile (Fig. 3, Fig. S3). We found five males and five 
419 females with coat color chimerism from six pregnant females (Fig. 5B). However, the 
420 incidence of chimerism was relatively low, about 5-30%, and two mice died at 2 and 3 
421 weeks of age, suggesting that CDGC1-P3-9 cells are not typical naïve pluripotent cells 
422 and/or have some abnormalities. The chimeric mice did not develop any tumors including 
423 teratomas. We are mating male chimeric mice with female MCH mice, but germ line 
424 transmission has not been observed so far. 
425
426 3.5 Paternal imprinting is established in CDGCs
427 We examined whether paternal imprinting was established in CDGCs that originated 
428 from the teratoma-forming cells in P2 testes. We examined H19 and Igf2 as paternally 
429 imprinted genes and Snrpn as a maternally imprinted gene, and found that H19 and Igf2 
430 were exclusively methylated, while Snrpn was exclusively de-methylated (Fig. 6), in both 
431 cell lines. These results suggested that paternal imprinting progresses normally in the 
432 teratoma-forming cells in neonatal testes and is maintained during the course of CDGC 
433 establishment. 
434
435 3.6 Teratoma-forming cells in the Dnd1ter/ter testis show a pluripotency-associated gene 
436 expression profile differing from that of ESCs 
437  To assess the similarity between teratoma-forming cells that initiate teratoma 
438 development in P2 testes and ESCs, we next compared the teratoma-forming cells in the 
439 Dnd1ter/ter testis with ESCs regarding the expression of pluripotency-associated genes. 
440 We randomly picked single Oct4-deltaPE-GFP-expressing cells from the teratoma-
441 forming cell clusters isolated from the Dnd1ter/ter testis at P2, as well as single ESCs 
442 cultured in the 2i/LIF condition, and performed single-cell RT-qPCR (Kurimoto et al., 
443 2006). Among the core and naïve pluripotency genes, Oct4 and Nanog were expressed in 
444 most single cells at levels comparable to those in ESCs, whereas the expression of Esrrb 
445 was lower in all single cells than that in ESCs. Sox2 and Tbx3 showed variable expression 
446 among the single cells (Fig. 7 and Fig. S7). 
447  Regarding the primed pluripotency genes, expression of Fgf5 and Otx2 was higher in 
448 the majority of single cells compared with that in ESCs, and Sox17 showed variable 






























































450 expression of a primed marker, Fgf5, in most single cells suggested that the majority of 
451 the teratoma-forming cells in P2 testis possesses a cellular status that resembles primed 
452 pluripotency. Some single cells such as #7, 8, 13, and 19 in Fig. 7 showed expression 
453 levels of Tbx3 similar to those observed with ESCs, and expression levels of Sox17 and 
454 Otx2 relatively lower than those observed with the rest of the single cells, suggesting that 




459  We successfully derived PSC lines, which we termed CDGCs, from teratoma-forming 
460 cells in the Dnd1ter/ter testis at P2 in medium containing serum/LIF. We showed that the 
461 CDGCs can be maintained in this condition as well as in the 2i/LIF condition (Fig. 2, Fig. 
462 S1). CDGCs differentiated into cells of the three germ layers including cardiac muscle, 
463 neurons, and endodermal cells in culture and contributed to chimeric mice (Fig. 5, Fig. 
464 S6). 
465 Pluripotency gene expression and global gene expression profiles suggested that 
466 CDGCs possess pluripotency intermediate between naïve and primed (Fig. 3, Fig. 4). In 
467 addition, CDGC1-P3-9 was easily adapted to the EpiSC culture condition (Fig. S5). 
468 Immunostaining of CDGCs with an anti-OTX2 antibody indicated that some cells in 
469 CDGCs showed higher expression of OTX2 compared to that in other cells (Fig. S2), 
470 suggesting that CDGCs are maintained as a mixture of cells with relatively naïve and 
471 primed pluripotency. The gene expression profiles suggested that CDGC6-P5-6 may be 
472 in a state resembling naïve pluripotency (Fig. 3, Fig. 4). Subtle differences in culture 
473 conditions during establishment of CDGC lines may have resulted in distinct expression 
474 of pluripotency genes in the two CDGC lines. The differential gene expression between 
475 the two CDGC lines likely reflects the nature of the teratoma-forming cells from which 
476 the CDGCs originated, because the teratoma-forming cells in the Dnd1ter/ter testis at P2 
477 are heterogeneous with regard to the expression of some naïve and primed pluripotency 
478 genes, such as Tbx3 and Sox17 (Fig. 7, Fig. S7). 
479 Single-cell RT-qPCR showed that the expression of a primed pluripotency gene, Fgf5, 
480 and a naïve pluripotency gene, Esrrb, was higher and lower, respectively, in most 
481 teratoma-forming cells than in ESCs; in contrast, other naïve and primed pluripotency 






























































483 teratoma-forming cells. Together, these results suggested that pluripotency in the 
484 teratoma-forming cells in the testes is related to the primed or intermediate pluripotent 
485 status. Consistent with this hypothesis, when germ cells in embryonic testes develop 
486 teratomas, the germ cells first form an epiblast-like structure, and a recent study revealed 
487 that germ cells acquire primed pluripotency during the course of teratoma formation 
488 (Dawson et al., 2018). Previous observations indicated that immature tissues are observed 
489 at P10 (Stevens, 1981), and well-developed teratomas that appear 2-3 weeks after birth 
490 consist primarily of differentiated cells (Stevens, 1983). Our results also showed that 
491 differentiating teratoma cells were observed as early as P4 in our experimental conditions. 
492 The results together support the idea that the teratoma-forming cells are pluripotent. The 
493 teratoma-forming cells with a relatively more naïve or primed status may adapt in the 
494 serum/LIF culture condition to yield PSCs that partially reflect the original pluripotent 
495 status. Overall expression profiles of pluripotency genes in CDGCs, especially CDGC1-
496 P3-9, resembled those of some teratoma-forming cells, suggesting that CDGCs represent, 
497 at least in part, the cellular status of the teratoma-forming cells in vivo. The efficiency of 
498 chimeric mouse formation by CDGCs was low (Fig.5B), similar to that of traditional 
499 ECCs, and some chimeric mice containing CDGCs died shortly after birth, suggesting 
500 that the pluripotency of CDGCs was not a typical naïve status.
501  In addition to LIF, bFGF is essential for reprogramming of PGCs into pluripotent EGCs 
502 (Mtasui et al., 1992; Resnick et al., 1992), and germ cells isolated after E14.5 rarely 
503 develop into EGCs (Kimura et al., 2007; Matsui et al., 2014). In the case of SSC-derived 
504 PSCs, glial cell-derived neurotrophic factor (GDNF) is essential, and PSCs have not been 
505 obtained from SSCs in ESC medium after several experiments (Kanatsu-Shinonara et al., 
506 2004). In contrast, CDGCs were derived from the P2 testis in ESC medium containing 
507 LIF but not in medium containing bFGF or GDNF. This result suggested that the 
508 teratoma-forming cells are distinct from PGCs and SSCs, which are not themselves 
509 pluripotent. Consistent with this inference, transcriptomic analysis showed that gene 
510 expression in CGDCs was distinct from that in germ cells in embryonic testes (Fig. 4, 
511 Fig. S4). Nevertheless, we found that paternal imprinting was established in CDGCs (Fig. 
512 6), suggesting that establishment of paternal imprinting proceeds normally during 
513 conversion of embryonic male germ cells into teratoma-forming cells. Dnd1-deficient 
514 germ cells may differentiate normally, thereby yielding gonocytes and permitting the 






























































516 pluripotency. Alternatively, Dnd1-deficient germ cells may maintain potential 
517 pluripotency in PGCs while also permitting the establishment of the paternal imprinting.
518   Our results indicated that PSCs can be derived from the nascent teratoma-forming cells 
519 in the Dnd1ter/ter testis at P2. Because Dnd1 deficiency did not significantly affect global 
520 gene expression in ESCs (Fig. 4), establishment of CDGCs from the teratoma-forming 
521 cells as PSCs and their adaptation to the culture condition for naïve pluripotency likely 
522 are not due to the loss of Dnd1. Therefore, ECCs with normal Dnd1 also may be 
523 maintained in the naïve pluripotency condition, although this possibility will need to be 
524 tested in future studies. Additionally, more detailed analyses of teratoma-forming cells, 
525 including identification of key genes specifically expressed in the teratoma-forming cells, 
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716 The appearance of teratoma-forming cells in peri- and post-natal Dnd1ter/ter testes. HE-
717 staining (A) and immunostaining for SSEA1 (B) in the Dnd1ter/ter testis and Dnd1ter/+ or 
718 Dnd1+/+ testis at E18.5, P2, P4, and P7. Insets show higher magnification images of the 
719 rectangular areas. Brown staining in (B) indicates SSEA1-positive cells. Scale bars: 200 
720 μm for main photomicrographs, and 100 μm for insets.
721
722 Fig. 2
723 Derivation of cell lines from teratoma-forming cells in the Dnd1ter/ter testis at P2. (A, B) 
724 Appearance of Oct4-deltaPE-GFP-positive clusters of teratoma-forming cells in the 
725 Dnd1ter/ter testis at P2. Whole-mount images of the testes and isolated cell masses 
726 containing GFP-positive cells (A), and immunostaining for 4C9, GFP expression, and 
727 DAPI staining in a section of the testis shown in A (B). (C) Primary (upper two rows) and 
728 tertiary (third row) cultures of teratoma-forming cells. The bottom row shows an 
729 established CDGC cell line, CDGC1-P3-9, after cloning. (D) CDGC1-P3-9 cultured in 
730 the 2i/LIF condition. Scale bars: 500 μm for (A), 100 μm for inset in (A), and 250 μm for 
731 (B, C, D). 
732
733 Fig. 3
734 Quantification of pluripotent marker gene expression in CDGC1-P3-9, CDGC6-P5-6, and 
735 ESCs (E14tg2a) cultured in serum/LIF medium, and EpiSCs. Expression of the core 
736 pluripotency (A), naïve pluripotency (B), and primed pluripotency marker genes (C) was 
737 determined by quantitative RT-PCR (RT-qPCR). Data were obtained from three 
738 independent experiments. Error bars show mean ± SD. *p < 0.05, **p < 0.01, ***p < 
739 0.001, n.s.; not significant. 
740
741 Fig. 4
742 Transcriptomic analysis of CDGCs. (A) Scatter plot showing log10 fragments per 






























































744 9, CDGC6-P5-6, Dnd1-KD ESCs (E14tg2a), and control ESCs (E14tg2a) cultured in 
745 serum/LIF medium (data were obtained from two biological replicates of RNA-seq. 
746 GSE118582; Table S1), and EpiSCs_1 (SRR3317447_1, SRR3317447_2). Red and blue 
747 dots indicate genes with log2 fold change >2 or <−2, respectively. (B) Principal 
748 component analysis of CDGC1-P3-9, CDGC6-P5-6, control E14tg2a ESCs, Dnd1-KD 
749 E14tg2a ESCs (this study; GSE118582), D3 GFP ESC (SRR827706, SRR827707), 
750 EpiSC_1 (SRR3317447), EpiSC_2 (SRR1660269, SRR1660270), E11.5 male(m)PGCs 
751 (SRR648693, RSS648694), E13.5 mPGCs (SRR649339, SRR649340), and E16.5 male 
752 germ cells (mGS) (ERR192339;). x axis: Component 1 (62.87%), y axis: Component 2 
753 (11.65%), z axis: Component 3 (6.17%). 
754
755 Fig. 5
756 Differentiation potential of CDGC1-P3-9. (A) Differentiation of CDGC1-P3-9 cultured 
757 in serum/LIF medium into α-smooth muscle actin (α-SMA) -positive mesodermal cells, 
758 β-tubulin-positive neural cells, and FOXA2-positive endodermal cells. Scale bars: 100 
759 μm. (B) Male (left) and female (right) chimeric mice obtained from CDGC1-P3-9 
760 cultured in 2i/LIF medium.
761
762 Fig. 6
763 The DNA methylation status of paternally imprinted H19 and Igf2, and of maternally 
764 imprinted Snrpn, in CDGC1-P3-9 (A) and CDGC6-P5-6 (B). DNA methylation was 
765 determined by bisulfite sequencing. The filled and open circles indicate methylated and 
766 un-methylated CpGs, respectively. The data from two independent experiments were 
767 combined. The percentage of methylated CpGs is shown below each block of circles.
768
769 Fig. 7
770 Single-cell RT-qPCR of the teratoma-forming cells. The expression of pluripotency 
771 marker genes, and of Arbp as an internal control, in single teratoma-forming cells 
772 randomly selected from an Oct4-deltaPE-GFP-expressing cell cluster in the Dnd1ter/ter 
773 testis at P2 (Teratoma; yellow bars) and in single Blimp1-mVenus;Stella-ECFP (BVSC) 
774 ESCs cultured in 2i/LIF medium (ESC; blue bars) was quantitatively determined by RT-
775 qPCR. Results for 15 teratoma-forming cells (Teratoma_#7-21) are shown. Data in (A)-

































































780 Established CDGC6-P5-6 cultured in serum/LIF (A) or 2i/LIF (B) medium. Scale bars: 
781 250 μm. 
782
783 Fig. S2
784 Immunostaining for OTX2 of BVSC ESCs cultured in 2i/LIF medium and EpiLCs 
785 differentiated from BVSC ESCs (A), and CDGCs cultured in serum/LIF medium (B). 
786 Right panels of each cell line show the magnified views of the boxed areas in the 
787 respective left panels. Arrowheads and arrows in (B) indicate cells with strong and weak 
788 Oct4-deltaPE-GFP signals, respectively. Scale bars: 50 μm.
789
790 Fig. S3 
791 Quantification of pluripotent marker gene expression in CDGC1-P3-9, CDCG6-P5-6, and 
792 BVSC ESCs cultured in 2i/LIF medium. The expression of the core pluripotency (A), 
793 naïve pluripotency (B), and primed pluripotency marker genes (C) was determined by 
794 quantitative RT-PCR (RT-qPCR). Data were obtained from three independent 
795 experiments. Error bars show mean ± SD. p-values are indicated. 
796
797 Fig. S4
798 A heat map showing expression of pluripotency genes and male germ cell marker genes 
799 in CDGC1-P3-9, CDGC6-P5-6, control E14tg2a ESCs, (data were obtained from two 
800 biological replicates of RNA-seq. GSE118582), E11.5 male(m)PGCs (SRR648693, 
801 RSS648694), E13.5 mPGCs (SRR649339, SRR649340), and E16.5 male germ cells 
802 (mGS) (ERR192339). Relative miRNA expression is described according to the color 
803 scale. Red and blue indicate high and low expression, respectively. Corresponding 
804 fragments per kilobase of exon per million reads mapped (RPKM) values of the RNA-
805 seq data are shown in Table S2. 
806
807 Fig. S5
808 CDGC1-P3-9 cultured in the ESC condition (serum/LIF; the first column) and in the 






























































810 anti-OCT4 antibody. Scale bars: 100 μm.
811
812 Fig. S6
813 Differentiation of CDGC6-P5-6 cultured in serum/LIF medium into α-smooth muscle 
814 actin(α-SMA) -positive mesodermal cells, β-tubulin-positive neural cells, and FOXA2-
815 positive endodermal cells. 
816
817 Fig. S7 
818 Single-cell RT-qPCR of teratoma-forming cells. The expression of pluripotency marker 
819 genes, and of Arbp as an internal control, in single teratoma-forming cells randomly 
820 selected from an Oct4-deltaPE-GFP-expressing cell cluster in the Dnd1ter/ter testis at P2 
821 (Teratoma; yellow bars) and in single BVSC ESCs cultured in 2i/LIF medium (ESC; blue 
822 bars) was quantitatively determined by RT-qPCR. Results for six teratoma-forming cells 
823 (Teratoma_#1-6) are shown. Data in (A)-(E) were obtained in distinct PCR experiments. 
824 The vertical axis indicates Ct values of RT-qPCR. 
825
826 Table S1
827 List of genes exhibiting significant (q < 0.05) up-regulation or down-regulation (log2 fold 
828 change >2 or <−2, respectively) between ESCs (E14tg2a) and CDGC1-P3-9, between 




833 RPKM values of pluripotency and male germ cell marker genes. The data presented here 
834 correspond to those used in Fig. S4.
835
836 Table S3
837 PCR primers used in this study.
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